Koninklijke Philips (RYLPF) Liabilities and Shareholders Equity (2009 - 2026)
Koninklijke Philips (RYLPF) recorded quarterly Liabilities and Shareholders Equity of $31.9 billion in Q1 2026, up 1.78% quarter-over-quarter from $31.4 billion in Q4 2025, and up 11.71% on a YoY basis from $28.6 billion in Q1 2025.
Koninklijke Philips (RYLPF) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends
Koninklijke Philips' Liabilities and Shareholders Equity history runs 18 years deep, the most recent figure standing at $31.9 billion for Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity rose 11.71% year-over-year to $31.9 billion; the TTM figure through Mar 2026 stood at $123.9 billion (up 35.78% YoY), while the FY2025 annual figure was $31.4 billion, up 1.29% from the prior year.
- Liabilities and Shareholders Equity was $31.9 billion for Q1 2026 at Koninklijke Philips, up from $31.4 billion in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $34.7 billion in Q2 2022 to a low of $28.6 billion in Q1 2025.
- Historically, Liabilities and Shareholders Equity has averaged $31.4 billion across 5 years, with a median of $31.4 billion in 2025.
- The sharpest annual moves came in 2022 and 2026: Liabilities and Shareholders Equity fell 11.6% in 2022, then advanced 11.71% in 2026.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $31.3 billion in 2022, then climbed by 1.05% to $31.6 billion in 2023, then retreated by 2.13% to $31.0 billion in 2024, then gained by 1.29% to $31.4 billion in 2025, then gained by 1.78% to $31.9 billion in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $31.9 billion (Q1 2026), $31.4 billion (Q4 2025), and $30.8 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 10.74 Bn |
| 10 | Koninklijke Philips | - | - | 2.07 Bn | 31.92 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.92 Bn |
| Dec 31, 2025 | 31.36 Bn |
| Sep 30, 2025 | 30.79 Bn |
| Jun 30, 2025 | 29.86 Bn |
| Mar 31, 2025 | 28.58 Bn |
| Dec 31, 2024 | 30.96 Bn |
| Jun 30, 2024 | 31.74 Bn |
| Dec 31, 2023 | 31.64 Bn |
| Jun 30, 2023 | 32.13 Bn |
| Dec 31, 2022 | 31.31 Bn |
| Jun 30, 2022 | 34.67 Bn |
| Dec 31, 2021 | 35.42 Bn |
| Jun 30, 2021 | 34.93 Bn |
| Dec 31, 2020 | 33.04 Bn |
| Jun 30, 2020 | 30.27 Bn |
| Dec 31, 2019 | 29.90 Bn |
| Jun 30, 2019 | 29.61 Bn |
| Dec 31, 2018 | 29.70 Bn |
| Jun 30, 2018 | 29.63 Bn |
| Dec 31, 2017 | 29.81 Bn |